New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular disease-Reference-Cited by-同舟云学术

New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular disease

Published:2018-03 Issue: Volume:131 Page:176-189
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Wu Man,White Hayley V.,Boehm Blake A.,Meriney Christopher J.,Kerrigan Kaylan,Frasso Michael,Liang Mary,Gotway Erika M.,Wilcox Madeleine R.,Johnson Jon W.,Wipf Peter,Meriney Stephen D.

Funder

Muscular Dystrophy Association

National Institutes of Health

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference51 articles.

1. Local anesthetic and antiepileptic drug access and binding to a bacterial voltage-gated sodium channel;Boiteux;P.N.A.S,2014

2. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine;Buraei;Biophys. J.,2005

3. The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels;Buraei;J. Neurochem.,2008

4. Voltage control of Ca2+ permeation through N-type calcium (Ca(V)2.2) channels;Buraei;J. Gen. Physiol.,2014

5. The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction;Cho;Eur. J. Neurosci.,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers;Current Therapeutic Research;2023

2. Inhibition of NMDA receptors through a membrane-to-channel path;Nature Communications;2022-07-15

3. Activation of Voltage-Gated Na+ Current by GV-58, a Known Activator of CaV Channels;Biomedicines;2022-03-20

4. Suppression of ventricular arrhythmias by targeting late L-type Ca2+ current;Journal of General Physiology;2021-10-26

5. A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs;Journal of Biological Chemistry;2021-01